990x120-1

The Past, Present, and Future of Gene Therapy: How to Scale-up Successfully

Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research.

In this episode, Niki Spahich from The Scientist’s Creative Services team spoke with Josh Snow, Director of Business Development and Marketing Strategy at Mirus Bio, about the past, present, and future of gene therapy, with a focus on how researchers can transition their successful therapies to clinical trials and the market, and the costs involved.

This episode is brought to you by Mirus Bio. Mirus Bio pioneered scientific breakthroughs in non-viral gene delivery and continues to produce world-class transfection reagents. Now as a global leader in transfection technology, Mirus Bio provides life scientists with the most advanced tools for gene expression, biotherapeutic protein production, virus manufacturing and genome editing.
Mirus-Logo 
 


Speaker

Snow.jpg
Josh Snow, PhD
Director
Business Development and Marketing Strategy
Mirus Bio

Listen Now

Podcast


Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.